Letter to the editor: Spontaneous regression of cirrhosis: A paradigm shift in our understanding of the natural history of NASH
Arka De, Amarjit Keisham, Ajay Duseja – 30 January 2022
Arka De, Amarjit Keisham, Ajay Duseja – 30 January 2022
Heather Francis, Debjyoti Kundu, Leonardo Baiocchi – 30 January 2022
Arun J. Sanyal, Chuhan Chung, Robert P. Myers, Jaime Bosch – 30 January 2022
Vivian Huang, Clem Lewin, Patricia Novy – 30 January 2022
Rachel J. Berkowitz, Milo C. Engoren, Graciela Mentz, Pratima Sharma, Sathish S. Kumar, Ryan Davis, Sachin Kheterpal, Christopher J. Sonnenday, Nicholas J. Douville – 30 January 2022 – Acute kidney injury (AKI) is one of the most common complications of liver transplantation (LT). We examined the impact of intraoperative management on risk for AKI following LT. In this retrospective observational study, we linked data from the electronic health record with standardized transplant outcomes.
Serena Del Turco, Valentina Cappello, Christos Tapeinos, Aldo Moscardini, Laura Sabatino, Matteo Battaglini, Fabio Melandro, Francesco Torri, Caterina Martinelli, Serena Babboni, Beatrice Silvestrini, Riccardo Morganti, Mauro Gemmi, Paolo De Simone, Paulo N. Martins, Laura Crocetti, Adriano Peris, Daniela Campani, Giuseppina Basta, Gianni Ciofani, Davide Ghinolfi – 30 January 2022 – The combined approach of ex situ normothermic machine perfusion (NMP) and nanotechnology represents a strategy to mitigate ischemia/reperfusion injury in liver transplantation (LT).
Ya Deng, Chun‐Yan Wang, Xiao‐Xia Niu, Dong Ji – 30 January 2022
Alexandra T. Strauss, Dorry L. Segev, William A. Werbel – 29 January 2022
James P. Stevens, Yijin Xiang, Traci Leong, Kushal Naik, Nitika Arora Gupta – 28 January 2022 – Children who undergo liver transplantation are at risk for portal vein complications (PVCs) including thrombosis (PVT) and stenosis (PVS). Using multicenter data from the Society of Pediatric Liver Transplantation, we analyzed the prevalence, timing, and risk factors for PVC following a first liver transplantation, and assessed the potential impact of PVC on patient outcomes. Our cohort included 4278 patients, of whom 327 (7.6%) developed PVC.
James E. Squires, Anthony J. Demetris – 28 January 2022